Swiss Finance Corporation (Mauritius) has sold 3.70 lakh shares of Strides Arcolab through the open market route. The shares were sold on an average price of Rs 1060 valuing the transaction to Rs 39.32 crore.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.